Intellia Phase 1/2 Clinical Trial Authorized for Hereditary Angioedema Treatment

https://ir.intelliatx.com/news-releases/news-release-details/intellia-therapeutics-receives-authorization-initiate-phase-12
Join the IPIRA Mailing List

 

 
 
 
 

 

Accessibility | Nondiscrimination | Privacy